Ranbaxy fastest growing pharma firm in Q1 this year: IMS

According to market research firm IMS, it clocked sales growth of 17.3 per cent from January-March, over the same period last year, although it remained second in terms of market share with 4.78 per cent.

Ranbaxy was the fourth fastest growing firm, at 14 per cent, in the same period last year. Meanwhile, Cipla was the second fastest growing firm at a rate of 12.1 per cent in the January-March period, but it retained top slot in market share at 5.39 per cent.

Last year, in the same period, Cipla was the second fastest growing firm at a rate of 16.9 per cent.

The third fastest growing company during the first quarter this calendar was GSK Pharmaceuticals at 7.9 per cent, over the same period last year. It had a growth of 14.9 per cent in the same period last year.

In terms of market share this year, it garnered 4.03 per cent, occupying the third slot overtaking Piramal Healthcare.

As per the IMS data, Piramal Healthcare saw a massive decline in its growth rate to just 0.8 per cent during the quarter under review. The growth rate for the company in the corresponding period last year was at 22.3 per cent and it was fastest among the top four firms.

In terms of market share, Piramal Healthcare also saw it decline to 3.92 per cent for the Q1, 2011, thus slotted at the fourth position. In the same period last year, it had a market share of 4.41 per cent.

As per industry estimates, the Indian pharmaceutical market is estimated to be around Rs 50,000 crore at present.

DH Newsletter Privacy Policy Get top news in your inbox daily
GET IT
Comments (+)